Table 1. Patient characteristics.
| Characteristic | Datuma |
|---|---|
| Male:Female | 8:7 |
| Age | 66±11 (42–79) |
| Motor deficit (%) | 46.67 |
| Language deficit (%) | 33.33 |
| Karnofsky Performance Score | 89.33±9.61(70–100) |
| Volume of CER (mL) | 18.01±11.91 (7.34–49.85) |
| Volume of Necrosis (mL) | 6.60±5.77 (0.59–21.21) |
| Volume of NCER (mL) | 48.65±26.38 (16.45–119.23) |
| fCER (%) | 10.80±2.49 (7.28–15.12) |
| DCER (x10-3mm2/s) | 1.064±0.165 (0.804–1.378) |
| D*CER (x10-3mm2/s) | 24.665±5.140 (16.802–33.163) |
| ADCCER(x10-3mm2/s) | 110.78±18.13 (84.82–142.89) |
| rCBFCER (ml/100g/min) | 51.27±21.56 (18.69–86.91) |
| rCBVCER (ml/100g) | 4.69±1.59 (2.27–7.37) |
| max rCBFCER (ml/100g/min) | 151.63±21.01 (112–181.84) |
| max rCBVCER (ml/100g) | 12.73±3.31 (8.67–19.07) |
| fNCER (%) | 2.34±0.99 (1.02–3.83) |
| DNCER (x103mm2/s) | 1.488±0.270 (1.097–1.976) |
| D*NCER (x103mm2/s) | 4.632±2.264 (1.133–8.614) |
| rCBFNCER (ml/100g/min) | 23.65±10.71 (11.03–46.55) |
| rCBVNCER (ml/100g) | 1.47±0.76 (0.67–3.61) |
| Treatment (n) | |
| Standard | 5 |
| Non-standard (surgery only) | 8 |
| Non-standard (palliative care) | 2 |
| Survival (months) | 6.7±4.83 (1–21) |
| Standard treatment | 10.6±6.23 (5–21) |
| Non-standard (surgery only) | 4.81±2.53 (1–8.5) |
| Non-standard (palliative care) | 4.5±3.54 (2–7) |
aUnless otherwise specified, data are means ± standard deviations, with ranges in parentheses.